
Multicenter, double-blind, randomized, placebo-controlled trial evaluating the efficacy and safety of intermittent levosimendan in outpatients with advanced chronic heart failure: the LION Heart Study. Josep COMIN-COLET (Barcelona, Spain). ESC Heart Failure 2015 - 2nd World Congress on Acute Heart Failure 2015.